| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Douglas Carl Fisher | President | $433K | Feb 14, 2024 | ||
| Daniel E. Geffken | Chief Financial Officer | $100K | Feb 14, 2024 | ||
| Caroline M. Loewy | Director | $58.3K | Feb 14, 2024 | ||
| Barbara Kosacz | Director | $58.3K | Feb 14, 2024 | ||
| Lindsey Rolfe | Director | Mar 25, 2024 | |||
| Michael Byrnes | Director | Mar 25, 2024 | |||
| Brian G. Atwood | Chief Executive Officer, Director | Mar 25, 2024 | |||
| Christopher B. Ehrlich | Director | Mar 25, 2024 | |||
| Laporte Kathleen | Director | Mar 25, 2024 | |||
| Charles Carter | Chief Financial Officer | Jun 28, 2024 | |||
| Daniel Corey | Chief Technical Officer, Director | Mar 25, 2024 | |||
| Robyn Rapaport | Director | Mar 25, 2024 | |||
| Phoenix Biotech Sponsor, Llc | 10%+ Owner | Feb 14, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|